AVEO Oncology
AVEO
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)
Categories
AVEO Oncology (AVEO) - Total assets
Total assets on the balance sheet as of September 2022 : $0.10 B
According to AVEO Oncology 's latest financial reports the company's total assets are $0.10 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
AVEO Oncology - Total assets on balance sheet (from 2008 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2021-12-31 | $0.10 B | 57.43% |
| 2020-12-31 | $66.91 M | 32.24% |
| 2019-12-31 | $50.6 M | 81.13% |
| 2018-12-31 | $27.93 M | -44.35% |
| 2017-12-31 | $50.19 M | 83.98% |
| 2016-12-31 | $27.28 M | -32.7% |
| 2015-12-31 | $40.54 M | -42.63% |
| 2014-12-31 | $70.66 M | -51.72% |
| 2013-12-31 | $0.14 B | -29.46% |
| 2012-12-31 | $0.20 B | -29.68% |
| 2011-12-31 | $0.29 B | 95.34% |
| 2010-12-31 | $0.15 B | 152.4% |
| 2009-12-31 | $59.84 M | 49.28% |
| 2008-12-31 | $40.08 M | -40.75% |
| 2007-12-31 | $67.65 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $64.00 B | 63,126.71% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 95,870.68% | 🇺🇸 USA |
 Biogen BIIB | $26.84 B | 26,417.84% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $33.08 B | 32,577.29% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $95.15 B | 93,899.98% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $19.18 M | -81.05% | 🇺🇸 USA |